Narayana Hrudayalaya Ltd

₹ 753 0.19%
07 Dec - close price
About

Narayana Hrudalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]

Key Points

Hospitals Network
As per Sept 2021, the company owns and/or operates 47 healthcare facilities that consists of 20 owned hospitals, 2 managed hospitals, 5 heart centers, 19 primary healthcare facilities and 1 hospital in Cayman Islands. It has a capacity of ~6,800 beds out of which ~6,200 are operational.[1]

  • Market Cap 15,398 Cr.
  • Current Price 753
  • High / Low 820 / 545
  • Stock P/E 34.5
  • Book Value 88.1
  • Dividend Yield 0.13 %
  • ROCE 24.7 %
  • ROE 26.7 %
  • Face Value 10.0

Pros

  • Company has delivered good profit growth of 32.8% CAGR over last 5 years
  • Company's median sales growth is 21.4% of last 10 years

Cons

  • Stock is trading at 8.55 times its book value
  • Company has a low return on equity of 13.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
822 785 743 394 601 750 838 860 940 960 941 1,033 1,142
702 683 648 485 575 648 698 728 774 787 768 842 898
Operating Profit 120 102 95 -92 26 102 140 132 167 173 172 192 244
OPM % 15% 13% 13% -23% 4% 14% 17% 15% 18% 18% 18% 19% 21%
6 6 -4 5 10 5 8 7 12 7 10 8 31
Interest 22 21 21 20 19 19 18 17 17 16 16 15 15
Depreciation 43 46 55 46 46 46 44 45 46 46 47 47 49
Profit before tax 62 40 16 -153 -30 42 85 77 116 117 119 137 211
Tax % 27% 22% 23% 22% 88% 2% 20% 1% 14% 17% 42% 19% 20%
Net Profit 45 31 12 -120 -3 41 68 76 99 98 69 111 169
EPS in Rs 2.22 1.54 0.59 -5.86 -0.17 2.00 3.33 3.73 4.86 4.77 3.37 5.41 8.26
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
478 658 839 1,095 1,364 1,614 1,878 2,281 2,861 3,128 2,583 3,701 4,076
421 574 769 989 1,236 1,434 1,642 2,064 2,566 2,694 2,394 3,038 3,295
Operating Profit 57 84 70 106 128 180 236 217 295 434 189 664 781
OPM % 12% 13% 8% 10% 9% 11% 13% 10% 10% 14% 7% 18% 19%
3 3 28 39 6 -19 7 18 16 7 21 26 56
Interest 6 11 19 31 45 33 28 55 81 94 82 76 63
Depreciation 32 37 46 57 68 76 80 100 137 186 184 183 189
Profit before tax 21 39 34 57 21 51 135 80 93 161 -56 430 585
Tax % 34% 33% 29% 38% 71% 59% 39% 36% 37% 26% 75% 20%
Net Profit 14 26 24 29 -19 21 83 51 59 119 -14 342 446
EPS in Rs 419.18 791.33 762.14 974.49 -0.84 1.04 4.06 2.51 2.90 5.82 -0.70 16.73 21.81
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 35% 17% 0% 6%
Compounded Sales Growth
10 Years: 19%
5 Years: 15%
3 Years: 9%
TTM: 20%
Compounded Profit Growth
10 Years: 30%
5 Years: 33%
3 Years: 81%
TTM: 57%
Stock Price CAGR
10 Years: %
5 Years: 21%
3 Years: 36%
1 Year: 31%
Return on Equity
10 Years: 8%
5 Years: 10%
3 Years: 13%
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
0 0 0 0 200 204 204 204 204 204 204 204 204
Reserves 481 515 547 580 568 672 761 833 878 933 917 1,286 1,596
104 141 256 333 362 258 217 802 813 952 826 723 858
117 126 160 242 241 424 466 690 744 812 832 929 1,067
Total Liabilities 702 783 963 1,156 1,371 1,557 1,648 2,529 2,640 2,901 2,779 3,142 3,725
484 491 620 738 913 1,054 1,082 1,848 1,838 2,092 1,961 1,980 2,078
CWIP 46 87 44 20 20 14 53 35 56 12 20 67 121
Investments 0 0 7 51 52 87 96 9 17 86 120 132 163
172 205 292 346 385 402 417 637 729 711 678 963 1,364
Total Assets 702 783 963 1,156 1,371 1,557 1,648 2,529 2,640 2,901 2,779 3,142 3,725

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
30 53 45 110 77 174 219 182 279 443 304 485
-94 -92 -147 -168 -223 -150 -146 -520 -162 -189 -113 -267
51 38 108 57 140 18 -45 315 -27 -247 -194 -159
Net Cash Flow -13 -0 6 -1 -6 42 28 -22 89 7 -2 59

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 35 37 40 45 38 34 30 45 34 31 39 43
Inventory Days 62 52 60 64 56 48 45 56 48 35 32 30
Days Payable 126 131 121 198 146 152 173 200 177 177 221 180
Cash Conversion Cycle -28 -41 -21 -90 -51 -70 -98 -100 -95 -111 -150 -108
Working Capital Days -10 5 10 2 -3 -2 -9 -4 -8 -17 -17 -0
ROCE % 8% 5% 8% 7% 9% 14% 9% 9% 14% 2% 25%

Shareholding Pattern

Numbers in percentages

8 recently
Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85 63.85
11.95 9.58 9.28 8.54 8.95 10.96 10.12 10.74 10.80 10.64 10.03 9.55
16.94 19.44 19.96 21.09 21.18 19.59 20.05 19.63 18.96 18.34 17.85 16.62
6.55 6.41 6.19 5.81 5.32 4.89 5.27 5.08 5.69 6.47 7.59 9.28
0.72 0.72 0.71 0.71 0.71 0.71 0.71 0.70 0.70 0.70 0.69 0.69

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Concalls